Genesis Healthcare Co. adopts Illumina microarray

Japan’s leading gene test company which commands about 80 % of the Japanese genetic testing market has decided to switch its microarray supplier from Thermo Fisher to a customized array of Illumina which contains SNPs from over 500.000 people, including East Asians. Genesis Healthcare aims to construct a genetic information database of 1 million people by 2019 and cooperates with IBM Japan.

Genesis Healthcare news release, May 29, 2017

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny